3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
34
Phase 1
12
Phase 1/2
6
Phase NA
2
Phase 4
1
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Leukemia, Myeloid, Acute
4
Lymphoma
3
Neoplasm, Residual
2
Lymphoma, Non-Hodgkin
2
Breast Neoplasms
2
Retinoblastoma
1
Recurrence
1
Prostatic Neoplasms
1
Neuroblastoma
1
Neoplasms
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Mediastinal Neoplasms
1
Lymphoma, Large-Cell, Anaplastic
1
Leukemia
1
Hepatoblastoma
1
Chemotherapy-Induced Febrile Neutropenia
1
Burkitt Lymphoma
1
Interventions
posaconazole
2
fludarabine
2
Cyclophosphamide
2
Busulfan
2
fludarabine phosphate
1
eltrombopag
1
Thiotepa
1
Radiotherapy
1
Peripheral Blood Stem Cell Transplantation
1
Micafungin
1
Idarubicin
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Decitabine
1
Cytarabine
1
Cholecalciferol
1
Bone Marrow Transplantation
1
Azacitidine
1
Antilymphocyte Serum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Myelodysplastic Syndromes
×
Granulocyte Colony-Stimulating Factor
×
Clear all
NCT00487448
2008-11-19
FLAG-IDA
PETHEMA Foundation
Phase 4
Completed
200 enrolled